Nyxoah SA revenue for the last year amounted to 4.80 M USD, the most of which — 4.80 M USD — came from its highest performing source at the moment, Hypoglossal Neurostimulations Therapy, the year earlier bringing 3.30 M USD. The greatest contribution to the revenue figure was made by Germany — last year it brought Nyxoah SA 4.21 M USD.